ImetelChat

Part 1: Just what is confirmation bias (CB)? Many definitions exist for CB but most reflect the following: A CB is when a person selectively seeks out information that supports a belief or idea that they already have, thus 'confirming' their existing beliefs. CB is the propensity to collect proof th...

Current executive employees with new / additional titles and responsibilities (1) On January 29, 2019, the Compensation Committee approved the appointment of Ms. Behrs as the Company’s Chief Business Officer. Melissa A. Kelly Behrs has been appointed Chief Business Officer and will be responsible f...

Thanks to Fan and hunter on YMB for supplying this info from LinkedIn: https://www.linkedin.com/jobs/view/life-science-contracts-attorney-at-geron-corporation-1017283366/ Note this job request on LinkedIn is no longer accepting applications. Life Science Contracts Attorney Company NameGeron Corporat...

It might be useful for us to keep information regarding Geron jobs and personnel in a single thread for easy reference. For those wanting to see current opportunities or apply you can go to: https://www.geron.com/careers/opportunities/ To Apply Geron is always accepting applications for employment o...

ashah thanks for your thoughts on this thread. I assume you have contacted Geron HR directly and forwarded your resume specifically to HR. I would certainly concur that believing in the drug and thinking outside the box to accelerate the process to commercialization and finding ways to cost effectiv...

Well I agree that we are and should be alert to all things management and stewardship related with JS, his BoD as well as the team being assembled. Most of us are concerned with the deafening silence about the 9-27-18 breakup, and more deafening silence regarding the momentous Dr. Tefferi days and p...

While we don’t know all the details or even some of the most critical material facts, I think most agreed the JS scenario for success via the JNJ/Janssen CLA was likely the best path forward based on events and knowledge at the time in 2014. And on many levels it was confirmation that we had somethi...

#4 of top ten CROs in 2018.

https://www.igeahub.com/2018/03/15/top- ... -2018/amp/

Maybe I should be, but I’m not alarmed on why there are only 7 still in treatment in the MF CT. While yes, I don’t believe there is much room for compassion in CTs, it does seem to me it was probably arbitrary, given the strict nature of CTs and the FDA’s regulations/guidelines, etc. Possibly the pr...

One common thought if we want to be involved in activist activities, is to focus on appealing to significant stakeholders outside of Geron. Kmail’s dialogue with the FDA is an example. We know there are many avenues in addition to the FDA/EUA including respectable medical media and media outlets in ...

While redundant for those of us who follow some of the GERN YMB posts, I felt these two posts were of great interest to all those following the progress and activities around efforts to commercialize Imetelstat. There were also several interesting and useful replys to both post and if you access the...

Thanks Bucbeard for the kind words and your thoughtful comments as well. Yes, in this endeavor especially, we can all find value in applying the best version of ourselves to advance this cause. I, along with many, including yourself, biopearl and karagozoglu12345, have shared their concerns regardin...

Wow!! When an 8 part reduction becomes an expansion!

First, I certainly believe that JS/Geron/IR are underestimating, probably intentionally, the percentage of the 60K investors in the stock that have those very same questions. SA alone has over 30K following Geron related articles/newsreleases/conference calls/comments etc. so while not all will agre...

Happy New Year biopearl, a great post to start the year! I agree with your predictions and don't think anyone could say it better. Thanks for all your contributions to this web site and the Imetelstat endeavor!

biopearl123, I think those are great thoughts and your interpretation seems accurate to me. Yes there is a lot going on here, some even obvious to someone like myself, not knowledgeable in the science. It seems that every piece of data presented raises new possibilities or questions. Since it is jus...

Karagozoglu12345, check your email for letter updates.

I am not sure you are looking for me to do this but here is my hurried cut, I hope it helps. I won't have much time from here until after Christmas. Your Letter to JS/Geron Dear Dr. Scarlett: Please read this letter and respond freely with the level of detail a most knowledgeable investor and patien...

Well just so you know, I am also in the club with greater than a half million in losses and they are not all paper losses as many options have gone up in smoke as did another chunk today. I likely resonate your pain in all the dimensions you eluded to in your post. Like I said I’m not best suited to...

karagozoglu12345 , I suspect I am not your most effective option here but I could take a cut at editing your letter assuming you don’t have other volunteers. I would have to say that while the questions are good the tone is contentious. I would prefer, that while still being very direct, avoiding po...